Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

School children in Switzerland show willingness to mask-wearing

A school-based survey has revealed that about 60% of students in Zurich perceive mask-wearing at school as a useful intervention for controlling SARS-CoV-2 transmission.

10 Sep 2021

SARS-CoV-2 transmission dynamics in Nordic countries

Scientists have recently assessed the strategies adopted by the Nordic countries to curb the trajectory of the COVID-19 pandemic.

10 Sep 2021

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

Scientists evaluated the effect of vaccination in breastfeeding women and its possible effects in infants in a study involving 180 fully vaccinated, breastfeeding women.

10 Sep 2021

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

A group of researchers analyzed the B cell response to SARS-CoV-2 in unexposed individuals.

10 Sep 2021

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

A COVID-19 vaccine, created from a virus-like nanoparticle that displays SARS-CoV-2 spike protein RBDs, effectively protects animal model from infection.

10 Sep 2021

Study shows how health insurance coverage changed during the COVID-19 pandemic

Nearly 2.7 million people in the U.S. lost their health insurance over a 12-week period in the spring and summer of 2020 during the COVID-19 pandemic, according to a new study led by researchers at Duke University and Indiana University-Purdue University Indianapolis.

9 Sep 2021

Autoimmune antibodies strongly linked to the severity of illness in COVID-19 patients

The presence of special immune system defense molecules, called autoimmune antibodies, has been strongly tied to how poorly people fare when hospitalized with COVID-19, a new study shows.

9 Sep 2021

KHN’s ‘What the Health?’: The future of public health

The covid-19 pandemic has shone a spotlight on public health, a key part of the health care system that usually operates in the background.

9 Sep 2021

Early impact of COVID-19 vaccines in Stockholm, Sweden

A study shows that the early programmatic effects of vaccinating high-risk individuals can reduce infection and mortality by SARS-CoV-2.

9 Sep 2021

Stimulus program increased low-income population’s spending, study reveals

The coronavirus pandemic disrupted the U.S. economy, yet the dynamics of micro-level consumer spending among low-income populations are not well understood.

9 Sep 2021

Understanding the changing coronavirus landscape

With the emergence of new SARS-CoV-2 variants such as beta and delta, people are not only getting a refresher course on the Greek alphabet but also experiencing confusion and anxiety about what the variants mean for public health.

9 Sep 2021

Research probes interaction between SARS-CoV-2 and influenza

Researchers from Germany and France tried to determine if epidemiological studies based on co-detection prevalence data can offer a reliable estimation of interactions among respiratory viruses. They designed a simulation study by building on a general epidemiological model of co-circulation of 2 respiratory viruses that cause seasonal epidemics.

8 Sep 2021

Combating the fourth wave of COVID-19 in Ontario

Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.

8 Sep 2021

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

Researchers in Japan have warned that the Mu (B.1.621) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – appears to be highly resistant to neutralization by sera from convalescent or vaccinated individuals.

8 Sep 2021

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.

8 Sep 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

School children in Switzerland show willingness to mask-wearing

SARS-CoV-2 transmission dynamics in Nordic countries

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

Study shows how health insurance coverage changed during the COVID-19 pandemic

Autoimmune antibodies strongly linked to the severity of illness in COVID-19 patients

KHN’s ‘What the Health?’: The future of public health

Early impact of COVID-19 vaccines in Stockholm, Sweden

Stimulus program increased low-income population’s spending, study reveals

Understanding the changing coronavirus landscape

Research probes interaction between SARS-CoV-2 and influenza

Combating the fourth wave of COVID-19 in Ontario

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Early implementation of social distancing policies results in smaller death tolls, but larger second waves

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Neuropsychiatric symptoms in children and adolescents with long COVID

The role of nanobodies in capturing and containing SARS-CoV-2

A ‘new deal’ between faith groups and government to support communities

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in